Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Small Cell Lung Carcinoma × durvalumab × Clear all

Phase

Status

Recruiting 11 Active not recruiting 11 Unknown 8 Completed 7 Not yet recruiting 4 Terminated 3 Withdrawn 1 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1 Adenocarcinoma of Lung 1 Adenocarcinoma Of Esophagus 1

Interventions

Etoposide 5 Radiotherapy 3 Docetaxel 2 Cisplatin 2 venetoclax 1 trametinib 1 tislelizumab 1 talazoparib 1 rovalpituzumab tesirine 1 regorafenib 1 olaparib 1 obatoclax 1 fludarabine phosphate 1 etoposide phosphate 1 enoxaparin sodium 1 durvalumab 1 alpha-Tocopherol 1 Vitamin E 1 Topotecan 1 Tomography, Optical Coherence 1 Thymalfasin 1 Taxes 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Paclitaxel 1 Microarray Analysis 1 Magnetic Resonance Spectroscopy 1 Isotretinoin 1 Irinotecan 1 Immunologic Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05572476 2024-06-05

LURBIMUNE

Institut Bergonié

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡